BIO-key International (BKYI) Earns “Buy” Rating from Maxim Group

BIO-key International (NASDAQ:BKYI)‘s stock had its “buy” rating restated by investment analysts at Maxim Group in a note issued to investors on Thursday. They currently have a $5.50 price target on the technology company’s stock. Maxim Group’s price target would suggest a potential upside of 184.97% from the company’s current price.

Shares of BIO-key International (NASDAQ:BKYI) traded up $0.15 on Thursday, reaching $1.93. The company had a trading volume of 818,700 shares, compared to its average volume of 18,386. BIO-key International has a 1 year low of $1.20 and a 1 year high of $3.67.

BIO-key International (NASDAQ:BKYI) last released its quarterly earnings data on Tuesday, November 14th. The technology company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.11). BIO-key International had a negative net margin of 106.55% and a negative return on equity of 37.54%. The company had revenue of $0.94 million during the quarter.

An institutional investor recently bought a new position in BIO-key International stock. Commonwealth Equity Services Inc acquired a new stake in BIO-key International, Inc. (NASDAQ:BKYI) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 79,130 shares of the technology company’s stock, valued at approximately $226,000. Commonwealth Equity Services Inc owned 1.22% of BIO-key International at the end of the most recent quarter. Institutional investors and hedge funds own 2.93% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at

BIO-key International Company Profile

BIO-key International, Inc develops and markets fingerprint biometric identification and identity verification technologies, cryptographic authentication-transaction security technologies, as well as related identity management and credentialing software solutions. The Company is also engaged in developing automated, finger identification technology that supplements or compliments other methods of identification and verification, such as personal inspection identification, passwords, tokens, smart cards, identity cards, public key infrastructure (PKI), credit card, passports, driver’s licenses, one-time password (OTP) or other form of possession or knowledge-based credentialing.

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with's FREE daily email newsletter.

Leave a Reply